Recruitment of older adults with type 2 diabetes into a community-based exercise and nutrition randomised controlled trial.
BACKGROUND
Recruitment of participants into long-term community-based lifestyle intervention trials, particularly adults with a chronic disease, is often slow and challenging. Currently there is limited data on successful recruitment strategies suitable for older adults with type 2 diabetes into community-based exercise and nutrition programs, and no information on cost estimates associated with such recruitment. The aim of this report is to describe the recruitment strategies used and the success of each approach in recruiting older adults with type 2 diabetes into a 6-month community-based exercise and nutritional supplementation randomised controlled trial (RCT). A secondary aim is to assess the costs associated with the recruitment methods used.


METHODS
The Resistance Exercise, Vitamin D and Muscle Protein Intervention Trial (REVAMP-IT) for type 2 diabetes is a 24-week RCT targeting 202 adults with type 2 diabetes which is designed to evaluate whether post-exercise ingestion of a whey- protein and vitamin D-enriched drink can enhance the effects of progressive resistance training (PRT) on glycaemic control, body composition and cardiometabolic health. Participants in this trial were randomly allocated to either: (1) the Lift for Life® community-based PRT program combined with additional whey protein and vitamin D, or (2) the Lift for Life® PRT program alone. Recruitment strategies included state and local newspaper and radio advertisements, targeted mail-outs, doctor and allied health referrals, community presentations, web-based media and word of mouth. The number of expressions of interest, participants screened and included in the trial, and how they first heard about the study were recorded by research staff during the screening process. Reasons for ineligibility or non-participation in the trial were also recorded as was the cost of each recruitment method used.


RESULTS
A total of 1157 expressions of interest were received over a 21-month recruitment period. Overall 959 (83 %) individuals were screened and found to be ineligible for the trial or chose not to participate or could not be contacted further following their initial enquiry. As a result, 198 participants were randomised to the 24-week intervention. The most effective recruitment strategies were targeted mass mail-outs (39 % of the total participant sample), state (27 %) and local (14 %) print media. In total recruitment expenditure was AUD$40,421, which equated to AUD$35 per enquiry and AUD$204 per eligible participant. Targeted mail-outs and state print media were the most expensive strategies each accounting for 38 % of total expenditure.


CONCLUSIONS
To recruit around 200 older adults with type 2 diabetes into a community-based lifestyle intervention trial in a timely manner, it is important to ensure that an adequate budget is allocated to recruitment as targeted mail-outs and state/local print media were the most costly but effective strategies.


BACKGROUND
Australian New Zealand Clinical Trials Registry reference ACTRN12613000592741 . Registered on 27 May 2013.
Institute for Physical Activity and Nutrition, Deakin University, Geelong, VIC, Australia. e.miller@deakin.edu.au.
Eliza G
EG
Miller
Institute for Physical Activity and Nutrition, Deakin University, Geelong, VIC, Australia.
Caryl A
CA
Nowson
Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia.
David W
DW
Dunstan
School of Public Health, Curtin University, Perth, WA, Australia.
Deborah A
DA
Kerr
School of Public Health, Curtin University, Perth, WA, Australia.
Vicky
V
Solah
Fitness Australia, Melbourne, VIC, Australia.
David
D
Menzies
Institute for Physical Activity and Nutrition, Deakin University, Geelong, VIC, Australia.
Robin M
RM
Daly
Exercise; Nutritional supplementation; Older adults; Randomised controlled trial; Recruitment strategies; Type 2 diabetes
BMC Public Health. 2012 Oct 04;12:843
23035666
Diabetes Spectr. 2015 May;28(2):99-105
25987808
BMC Med Res Methodol. 2009 Apr 27;9:27
19397816
PLoS Med. 2010 Nov 09;7(11):e1000368
21085696
Diabetes Care. 2002 Dec;25(12):2165-71
12453955
Contemp Clin Trials. 2007 Jul;28(4):472-81
17287149
BMC Med Res Methodol. 2010 Sep 27;10:85
20875119
Control Clin Trials. 2002 Apr;23(2):157-71
11943442
Cancer. 2008 Jun 1;112(11 Suppl):2593-606
18428192
BMC Res Notes. 2015 Apr 15;8:151
25884358
Diab Vasc Dis Res. 2006 Dec;3(3):202-15
17160917
Diabetes Metab J. 2012 Feb;36(1):1-5
22363915
Contemp Clin Trials. 2007 Sep;28(5):603-13
17433791
J Phys Act Health. 2016 Apr;13(4):409-15
26314087
Clin Trials. 2012 Feb;9(1):80-9
22064686
Trials. 2014 Nov 06;15:431
25376884
Control Clin Trials. 2004 Aug;25(4):335-52
15296809
Control Clin Trials. 1993 Apr;14(2 Suppl):52S-67S
8500313
BMC Med Res Methodol. 2009 Nov 25;9:78
19930724
Control Clin Trials. 1997 Aug;18(4):328-52
9257072
Trials. 2014 Aug 16;15:326
25128185
JAMA. 2007 May 16;297(19):2081-91
17507344
Med J Aust. 2015 May 18;202(9):470-1
25971562